Jennifer Ann Woyach, MD

Novel Agents in Elderly CLL: Should the Approach be Different?

10/25/2019

Q&As

Ibrutinib Combined With Obinutuzumab and Venetoclax for the Frontline Treatment of Older Patients With CLL

06/19/2023

At the 2023 ASCO annual meeting, Jennifer Ann Woyach, MD, shared data on ibrutinib combined with obinutuzumab and venetoclax vs ibrutinib plus obinutuzumab for the frontline treatment of older patients with CLL in the setting of the COVID-19...

At the 2023 ASCO annual meeting,...

06/19/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Jennifer Ann Woyach, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products